Literature DB >> 9606233

Baclofen overdose: drug experimentation in a group of adolescents.

H E Perry1, R O Wright, M W Shannon, A D Woolf.   

Abstract

BACKGROUND: Baclofen, a lipophilic analog of gamma-aminobutyric acid, is clinically used to control spasticity. We report a mass exposure to baclofen in adolescents seeking intoxication; toxicokinetic data are included. CASE SERIES: A group of adolescents became symptomatic after ingesting 3 to 30 20-mg tablets of baclofen during a party at a suburban Boys' Club. Several children were noted to be very lethargic by chaperones, ingestion was suspected, and paramedics were called. Some white tablets were found in a couch at the site of the party. The Massachusetts Poison Control Center was called, and the tablets were identified as baclofen (20 mg). Fourteen patients were taken to local hospitals; 9 required intubation. Eight adolescents were transferred to our institution. In these 8 patients, symptoms were noted within 1 to 2 hours after overdose. The most common clinical findings included coma (7), hypothermia (6), bradycardia (5), hypertension (4), and hyporeflexia (8). Mean length of mechanical ventilation was 40 hours. Three patients had unifocal premature ventricular contractions. Two patients had tonic-clonic seizures. A single dose of activated charcoal was given to all patients. Drugs administered included nifedipine (1), flumazenil (1), naloxone (1), lorazepam (2), and phosphenytion (2). All patients recovered and were discharged home within 5 days of ingestion. Serial serum baclofen levels were obtained in all intubated patients (range, 0.049 to 6.0; normal, 0.08 to .40 microgram/mL). Levels obtained 14 hours after ingestion showed a linear correlation with length of mechanical ventilation (R2 = 0.9863). Persistent symptoms were noted in some patients, despite nondetectable baclofen levels. Toxicologic screening for drugs of abuse was negative except in 2 patients with ethanol levels, both < 5 mg/dL.
CONCLUSION: Baclofen overdose may result in coma, apnea, autonomic disturbances, cardiac conduction abnormalities, and seizures. Levels obtained shortly after overdose correlate with length of mechanical ventilation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9606233     DOI: 10.1542/peds.101.6.1045

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  26 in total

1.  Baclofen intoxication: a "fun drug" causing deep coma and nonconvulsive status epilepticus--a case report and review of the literature.

Authors:  Guido F Weißhaar; Marc Hoemberg; Katja Bender; Ursula Bangen; Peter Herkenrath; Frank Eifinger; Markus Rothschild; Bernhard Roth; André Oberthuer
Journal:  Eur J Pediatr       Date:  2012-06-23       Impact factor: 3.183

2.  Baclofen overdose treated with continuous venovenous hemofiltration.

Authors:  Didier Meulendijks; Saheed Khan; Cornelis H W Koks; Alwin D R Huitema; Jan H M Schellens; Jos H Beijnen
Journal:  Eur J Clin Pharmacol       Date:  2015-01-09       Impact factor: 2.953

3.  Evaluation of peripheral versus central effects of GABA(B) receptor activation using a novel, positive allosteric modulator of the GABA(B) receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile.

Authors:  M Kalinichev; T Donovan-Rodriguez; F Girard; E Riguet; M Rouillier; B Bournique; H Haddouk; V Mutel; S Poli
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

4.  The use of opioids in children receiving intrathecal baclofen therapy.

Authors:  Giuliana Rizzo; Leonardo Bussolin; Lorenzo Genitori; Anna Zicca; Andrea Messeri; Matteo Lenge; Flavio Giordano
Journal:  Childs Nerv Syst       Date:  2019-04-26       Impact factor: 1.475

5.  Differential sensitivity to the motor and hypothermic effects of the GABA B receptor agonist baclofen in various mouse strains.

Authors:  Laura H Jacobson; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2005-01-25       Impact factor: 4.530

6.  Baclofen overdose mimicking anoxic encephalopathy: a case report and review of the literature.

Authors:  John J Miller
Journal:  Ther Adv Drug Saf       Date:  2017-02-01

7.  Haemodialysis clearance of baclofen.

Authors:  Miran Brvar; Matjaz Vrtovec; Damjan Kovac; Gordana Kozelj; Tomaz Pezdir; Matjaz Bunc
Journal:  Eur J Clin Pharmacol       Date:  2007-09-02       Impact factor: 2.953

8.  Baclofen intoxication after accidental ingestion in a 3-year-old child.

Authors:  Nagesh Dasarwar; Preeti Shanbag; Nilesh Kumbhare
Journal:  Indian J Pharmacol       Date:  2009-04       Impact factor: 1.200

9.  Quantitative pharmacokinetic-pharmacodynamic modelling of baclofen-mediated cardiovascular effects using BP and heart rate in rats.

Authors:  Harriet Kamendi; Herbert Barthlow; David Lengel; Marie-Eve Beaudoin; Debra Snow; Jerome T Mettetal; Russell A Bialecki
Journal:  Br J Pharmacol       Date:  2016-08-25       Impact factor: 8.739

Review 10.  A benefit-risk assessment of baclofen in severe spinal spasticity.

Authors:  Alessandro Dario; Giustino Tomei
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.